Related Experiment Videos
[Temporal cerebellar atrophy following phenytoin therapy]
A L Guerrero1, J A Paniagua, P Díaz Cascajo
1Servicio de Neurología, Hospital Universitario, Salamanca.
Neurologia (Barcelona, Spain)
|June 1, 1997
Summary
Phenytoin may cause progressive cerebellar degeneration, even at normal serum levels. This suggests a specific susceptibility of cerebellar cells to its toxicity in some patients with epilepsy.
Area of Science:
- Neurology
- Neuroscience
- Toxicology
Background:
- Epilepsy is a potential cause of acquired cerebellar degeneration.
- The exact cause is debated, including seizures, hypoxia, or antiepileptic drugs like phenytoin and carbamazepine.
Observation:
- A young male with partial seizures, treated with carbamazepine and later phenytoin, developed progressive cerebellar degeneration.
- Cerebellar atrophy was confirmed via CT and MR imaging over 18 months.
- Serum phenytoin levels remained within normal limits, and no acute toxicity symptoms were observed.
Findings:
- Phenytoin was identified as the likely cause of cerebellar atrophy in this patient.
- The rapid onset of degeneration suggests a heightened susceptibility of cerebellar cells to phenytoin toxicity.
Implications:
- This case highlights the potential for phenytoin to induce chronic cerebellar toxicity.
- Further research is needed to understand the mechanisms and identify susceptible individuals.